The technology, which can dramatically improve access to medicine, has already proved itself. America’s policies are lagging behind.

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Scientists report results from a promising new approach to treat the rare neurodegenerative disorder. Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before ...

What's the best way to safely and effectively deliver oxygen to patients in remote combat zones, rural hospitals or ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Jeff Jonas, portfolio manager at Gabelli Funds, said he’s surprised at the drop in Medtronic’s stock on the heels of its ...

Medtronic PLC's stock fell 7% as one of the worst performers in the S&P 500 on Tuesday after the medical-products company's earnings fell slightly short of Wall Street's revenue target despite a third ...

Discover why Medtronic's growth in robotics, AI, & solid fundamentals make it a Buy ahead of earnings. Read my analysis here.